David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$365M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$307M |
| 3 |
Adobe
ADBE
|
+$250M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Salesforce
CRM
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$520M |
| 2 |
ExxonMobil
XOM
|
+$372M |
| 3 |
Bank of America
BAC
|
+$271M |
| 4 |
Netflix
NFLX
|
+$172M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.36% |
| 2 | Technology | 13.15% |
| 3 | Financials | 9.51% |
| 4 | Healthcare | 7.52% |
| 5 | Consumer Discretionary | 6.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
MiMedx Group
MDXG
$657M
| $1.34M | ﹤0.01% |
466,937
-89,372
| -16% | -$318K |
|
3202
Varex Imaging
VREX
$780M
| $1.34M | ﹤0.01% |
63,314
-5,349
| -8% | -$117K |
|
|
WEL
3203
DELISTED
Integrated Wellness Acquisition Corp
WEL
| $1.34M | ﹤0.01% |
132,350
| – | – |
|
3204
PUT
Allegiant Air
ALGT
$2.2B
| $1.34M | ﹤0.01% |
+18,300
| New | +$1.89M |
|
3205
Advanced Energy
AEIS
$11.4B
| $1.33M | ﹤0.01% |
17,241
-41,289
| -71% | -$3.54M |
|
|
GXII
3206
DELISTED
GX Acquisition Corp. II Class A Common Stock
GXII
| $1.33M | ﹤0.01% |
136,050
| – | – |
|
3207
CALL
Kraft Heinz
KHC
$29.8B
| $1.33M | ﹤0.01% |
40,000
| – | – |
|
|
MTAL
3208
DELISTED
Metals Acquisition
MTAL
| $1.33M | ﹤0.01% |
136,300
| – | – |
|
3209
PUT
Jazz Pharmaceuticals
JAZZ
$16.3B
| $1.33M | ﹤0.01% |
10,000
| – | – |
|
3210
CALL
Vale
VALE
$65.2B
| $1.33M | ﹤0.01% |
100,000
-140,700
| -58% | -$1.85M |
|
|
AKRO
3211
DELISTED
Akero Therapeutics
AKRO
| $1.33M | ﹤0.01% |
39,023
+28,353
| +266% | +$434K |
|
|
CVET
3212
DELISTED
Covetrus, Inc. Common Stock
CVET
| $1.33M | ﹤0.01% |
63,547
-238,534
| -79% | -$4.97M |
|
|
OKLO
3213
Oklo
OKLO
$7.93B
| $1.32M | ﹤0.01% |
135,678
| – | – |
|
3214
United Bankshares
UBSI
$6.47B
| $1.32M | ﹤0.01% |
+36,948
| New | +$1.38M |
|
|
SGFY
3215
DELISTED
Signify Health, Inc.
SGFY
| $1.32M | ﹤0.01% |
45,331
+12,424
| +38% | +$286K |
|
3216
Target Hospitality
TH
$1.88B
| $1.32M | ﹤0.01% |
+104,549
| New | +$1.31M |
|
3217
PUT
Green Plains
GPRE
$986M
| $1.31M | ﹤0.01% |
+45,200
| New | +$1.53M |
|
3218
Groupon
GRPN
$795M
| $1.31M | ﹤0.01% |
164,636
+81,834
| +99% | +$890K |
|
3219
Cirrus Logic
CRUS
$5.55B
| $1.31M | ﹤0.01% |
19,039
+7,450
| +64% | +$585K |
|
|
SEMR
3220
DELISTED
Semrush
SEMR
| $1.31M | ﹤0.01% |
116,816
-3,172
| -3% | -$39K |
|
3221
Kopin
KOPN
$890M
| $1.31M | ﹤0.01% |
1,246,655
+305,679
| +32% | +$427K |
|
3222
Federal Realty Investment Trust
FRT
$10.2B
| $1.31M | ﹤0.01% |
14,513
-17,451
| -55% | -$1.77M |
|
3223
Dycom Industries
DY
$9.25B
| $1.31M | ﹤0.01% |
13,683
+2,500
| +22% | +$262K |
|
3224
AeroVironment
AVAV
$7.77B
| $1.3M | ﹤0.01% |
+15,642
| New | +$1.4M |
|
3225
Eldorado Gold
EGO
$12.5B
| $1.3M | ﹤0.01% |
216,341
-1,913
| -0.9% | -$11.2K |
|
Similar funds
David Shaw's Q3 2022 Portfolio in Review
As of Q3 2022, David Shaw held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
David Shaw withdrew a net $7.97B in Q3 2022, closing 678 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in Prologis worth $66.1M.
- David Shaw's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
- David Shaw added most to Visa in Q3 2022, an estimated $365M increase.
- David Shaw's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
- David Shaw fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
- David Shaw's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
- David Shaw opened 545 new positions and closed 678 in Q3 2022.
- David Shaw's portfolio value fell 1.8% quarter-over-quarter to $83.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.